Literature DB >> 28469784

Protective effect of Lagerstroemia speciosa against dextran sulfate sodium induced ulcerative colitis in C57BL/6 mice.

Ghanshyam Chaudhary1, Umesh B Mahajan1, Sameer N Goyal1, Shreesh Ojha2, Chandragouda R Patil1, Sandeep B Subramanya3.   

Abstract

The protective effect of methanolic extract of Lagerstroemia speciosaleaves (LS) was evaluated against dextran sulfate sodium (DSS) induced ulcerative colitis in C57BL/6 mice. The administration of DSS (2.5% in drinking water ad libitum) in C57BL/6 mice induced ulcerative colitis in 7 days. The LS was orally administered for 7 days at daily doses of 100 and 200 mg/kg. At the end of 7 days of treatment the animals were sacrificed, colonic tissues were removed and processed for further analysis of oxidative stress, and histopathology. In DSS treated mice the oxidative stress markers were elevated compared to controls. There was also significant reduction in the anti-oxidant defense levels marked by reduced cellular glutathione, catalase, and superoxide dismutase. The DSS-induced damage to the colon epithelium was evident from a significant increase in the lipid peroxidation. The histology of colon sections revealed inflammatory changes and marked impairment in the integrity of the mucosal lining with inflammatory changes. Both the doses of LS significantly prevented DSS-induced inflammatory and ulcerative damages of the colon, reduced lipid peroxidation and also restored the levels of innate antioxidants in the colon tissue. These findings indicate the protective effects of LS against the DSS-induced inflammatory and oxidative damage in the mouse colon. Further investigation involving bioactivity guided fractionation of the LS can yield potent constituent which may have a significant role in the treatment of inflammatory bowel disease and ulcerative colitis.

Entities:  

Keywords:  5-amino salicylic acid; DSS; lagerstroemia; oxidative stress; ulcerative colitis

Year:  2017        PMID: 28469784      PMCID: PMC5411927     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  26 in total

Review 1.  Pathway-based approaches to the treatment of inflammatory bowel disease.

Authors:  Giorgos Bamias; Theresa T Pizarro; Fabio Cominelli
Journal:  Transl Res       Date:  2015-09-07       Impact factor: 7.012

Review 2.  Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.

Authors:  J Langhorst; H Wulfert; R Lauche; P Klose; H Cramer; G J Dobos; J Korzenik
Journal:  J Crohns Colitis       Date:  2014-11-28       Impact factor: 9.071

Review 3.  When combination therapy isn't working: emerging therapies for the management of inflammatory bowel disease.

Authors:  Suneeta Krishnareddy; Arun Swaminath
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

4.  Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.

Authors:  Giovanni Monteleone; Markus F Neurath; Sandro Ardizzone; Antonio Di Sabatino; Massimo C Fantini; Fabiana Castiglione; Maria L Scribano; Alessandro Armuzzi; Flavio Caprioli; Giacomo C Sturniolo; Francesca Rogai; Maurizio Vecchi; Raja Atreya; Fabrizio Bossa; Sara Onali; Maria Fichera; Gino R Corazza; Livia Biancone; Vincenzo Savarino; Roberta Pica; Ambrogio Orlando; Francesco Pallone
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

5.  Preventive and therapeutic effects of blueberry (Vaccinium corymbosum) extract against DSS-induced ulcerative colitis by regulation of antioxidant and inflammatory mediators.

Authors:  Mehnaz Pervin; Md Abul Hasnat; Ji-Hong Lim; Yoon-Mi Lee; Eun Ok Kim; Byung-Hun Um; Beong Ou Lim
Journal:  J Nutr Biochem       Date:  2015-10-26       Impact factor: 6.048

6.  The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice.

Authors:  Leo R Fitzpatrick; Elizabeth Stonesifer; Jeffrey S Small; Karen T Liby
Journal:  Inflammopharmacology       Date:  2014-04-09       Impact factor: 4.473

Review 7.  A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid.

Authors:  Sidney J Stohs; Howard Miller; Gilbert R Kaats
Journal:  Phytother Res       Date:  2011-11-17       Impact factor: 5.878

8.  A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.

Authors:  Tohru Funakoshi; Kenichiro Yamashita; Nobuki Ichikawa; Moto Fukai; Tomomi Suzuki; Ryoichi Goto; Tetsu Oura; Nozomi Kobayashi; Takehiko Katsurada; Shin Ichihara; Michitaka Ozaki; Kazuo Umezawa; Satoru Todo
Journal:  J Crohns Colitis       Date:  2011-09-21       Impact factor: 9.071

Review 9.  Diagnosis and classification of ulcerative colitis.

Authors:  Karsten Conrad; Dirk Roggenbuck; Martin W Laass
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

Review 10.  Animal models of ulcerative colitis and their application in drug research.

Authors:  Daren Low; Deanna D Nguyen; Emiko Mizoguchi
Journal:  Drug Des Devel Ther       Date:  2013-11-12       Impact factor: 4.162

View more
  11 in total

1.  Nerolidol, a sesquiterpene, attenuates oxidative stress and inflammation in acetic acid-induced colitis in rats.

Authors:  Salim M A Bastaki; Naheed Amir; Ernest Adeghate; Shreesh Ojha
Journal:  Mol Cell Biochem       Date:  2021-05-17       Impact factor: 3.396

2.  Jianpi Qingchang Bushen decoction improves inflammatory response and metabolic bone disorder in inflammatory bowel disease-induced bone loss.

Authors:  Ya-Li Zhang; Qian Chen; Lie Zheng; Zi-Wei Zhang; Yu-Jun Chen; Yan-Cheng Dai; Zhi-Peng Tang
Journal:  World J Gastroenterol       Date:  2022-04-07       Impact factor: 5.374

3.  Antioxidant Activity of Acanthopanax senticosus Flavonoids in H2O2-Induced RAW 264.7 Cells and DSS-Induced Colitis in Mice.

Authors:  Jianqing Su; Xinyu Zhang; Qibin Kan; Xiuling Chu
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

4.  Lycopodium Mitigates Oxidative Stress and Inflammation in the Colonic Mucosa of Acetic Acid-Induced Colitis in Rats.

Authors:  Salim M A Bastaki; Naheed Amir; Ernest Adeghate; Shreesh Ojha
Journal:  Molecules       Date:  2022-04-26       Impact factor: 4.927

5.  Caffeic Acid Phenethyl Ester Attenuates Dextran Sulfate Sodium-Induced Ulcerative Colitis Through Modulation of NF-κB and Cell Adhesion Molecules.

Authors:  Ashok Kumar Pandurangan; Nooshin Mohebali; Mohadeseh Hasanpourghadi; Norhaizan Mohd Esa
Journal:  Appl Biochem Biotechnol       Date:  2022-01-18       Impact factor: 2.926

Review 6.  Chemical constituents and medicinal properties of Allium species.

Authors:  Salim M A Bastaki; Shreesh Ojha; Huba Kalasz; E Adeghate
Journal:  Mol Cell Biochem       Date:  2021-08-21       Impact factor: 3.396

7.  Chitosan Ameliorates DSS-Induced Ulcerative Colitis Mice by Enhancing Intestinal Barrier Function and Improving Microflora.

Authors:  Jia Wang; Cuili Zhang; Chunmei Guo; Xinli Li
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

Review 8.  Emerging Pathological Engagement of Ferroptosis in Gut Diseases.

Authors:  Weihua Gao; Ting Zhang; Hao Wu
Journal:  Oxid Med Cell Longev       Date:  2021-10-25       Impact factor: 6.543

9.  FOSL1 knockdown ameliorates DSS-induced inflammation and barrier damage in ulcerative colitis via MMP13 downregulation.

Authors:  Lizhuan Ma; Xiujing Zhang; Chao Zhang; Bingxu Hou; Hongtao Zhao
Journal:  Exp Ther Med       Date:  2022-07-01       Impact factor: 2.751

10.  Systems pharmacology approach reveals the antiinflammatory effects of Ampelopsis grossedentata on dextran sodium sulfate-induced colitis.

Authors:  You-Lan Chen; Ya-Li Zhang; Yan-Cheng Dai; Zhi-Peng Tang
Journal:  World J Gastroenterol       Date:  2018-04-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.